OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis
G. Grenet, Shams Ribault, Giao Bao Nguyen, et al.
PLoS ONE (2019) Vol. 14, Iss. 6, pp. e0217701-e0217701
Open Access | Times Cited: 15
G. Grenet, Shams Ribault, Giao Bao Nguyen, et al.
PLoS ONE (2019) Vol. 14, Iss. 6, pp. e0217701-e0217701
Open Access | Times Cited: 15
Showing 15 citing articles:
SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits
Elisa Marilly, Judith Cottin, Natalia Cabrera, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 2000-2010
Open Access | Times Cited: 63
Elisa Marilly, Judith Cottin, Natalia Cabrera, et al.
Diabetologia (2022) Vol. 65, Iss. 12, pp. 2000-2010
Open Access | Times Cited: 63
Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management
Kamlesh Khunti, Francesco Zaccardi, Aslam Amod, et al.
Diabetologia (2024)
Open Access | Times Cited: 8
Kamlesh Khunti, Francesco Zaccardi, Aslam Amod, et al.
Diabetologia (2024)
Open Access | Times Cited: 8
Oral GLP-1 analogue: perspectives and impact on atherosclerosis in type 2 diabetic patients
José Francisco Kerr Saraiva, Denise Reis Franco
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 28
José Francisco Kerr Saraiva, Denise Reis Franco
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 28
Comparative effectiveness of cardiovascular, renal and safety outcomes of second‐line antidiabetic drugs use in people with type 2 diabetes: A systematic review and network meta‐analysis of randomised controlled trials
Ruth Sim, Chun Wie Chong, Navin Kumar Loganadan, et al.
Diabetic Medicine (2021) Vol. 39, Iss. 3
Closed Access | Times Cited: 24
Ruth Sim, Chun Wie Chong, Navin Kumar Loganadan, et al.
Diabetic Medicine (2021) Vol. 39, Iss. 3
Closed Access | Times Cited: 24
Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmias
Aristi Boulmpou, Dimitrios Patoulias, Christodoulos Papadopoulos, et al.
Acta Cardiologica (2022) Vol. 78, Iss. 5, pp. 519-524
Closed Access | Times Cited: 11
Aristi Boulmpou, Dimitrios Patoulias, Christodoulos Papadopoulos, et al.
Acta Cardiologica (2022) Vol. 78, Iss. 5, pp. 519-524
Closed Access | Times Cited: 11
Glucagon-like peptide-1 receptor agonists or sodium–glucose cotransporter-2 inhibitors as add-on therapy for patients with type 2 diabetes? A systematic review and meta-analysis of surrogate metabolic endpoints
Dimitrios Patoulias, Alexandra Katsimardou, Maria Kalogirou, et al.
Diabetes & Metabolism (2020) Vol. 46, Iss. 4, pp. 272-279
Closed Access | Times Cited: 12
Dimitrios Patoulias, Alexandra Katsimardou, Maria Kalogirou, et al.
Diabetes & Metabolism (2020) Vol. 46, Iss. 4, pp. 272-279
Closed Access | Times Cited: 12
Fondamentaux de l’évaluation des thérapeutiques, médicamenteuses et non médicamenteuses – un cadre pour l’évaluation des processus d’autoguérison
François Gueyffier, Rémy Boussageon
HEGEL - HEpato-GastroEntérologie Libérale (2024) Vol. N° 4, Iss. 4, pp. 347-358
Closed Access | Times Cited: 1
François Gueyffier, Rémy Boussageon
HEGEL - HEpato-GastroEntérologie Libérale (2024) Vol. N° 4, Iss. 4, pp. 347-358
Closed Access | Times Cited: 1
Utilization of glucagon‐like peptide‐1 receptor agonists and changes in clinical characteristics in patients with type 2 diabetes by chronic kidney disease stage in Japan: A descriptive observational study using a nationwide electronic medical records database
Naoki Hirose, Naoto Tsujimoto, Taeko Katayose, et al.
Diabetes Obesity and Metabolism (2021) Vol. 24, Iss. 3, pp. 486-498
Open Access | Times Cited: 8
Naoki Hirose, Naoto Tsujimoto, Taeko Katayose, et al.
Diabetes Obesity and Metabolism (2021) Vol. 24, Iss. 3, pp. 486-498
Open Access | Times Cited: 8
Pragmatic trials, a step forward to assess cardiovascular efficacy of new glucose-lowering agents
André Scheen
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 9, pp. 626-627
Closed Access | Times Cited: 3
André Scheen
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 9, pp. 626-627
Closed Access | Times Cited: 3
Cardiometabolic risk profile of young and old adults with diabetes: Pooled, cross-sectional analysis of 42 national health surveys
Rodrigo M. Carrillo‐Larco, Wilmer Cristobal Guzman‐Vilca, Antonio Bernabé‐Ortiz
Primary care diabetes (2023) Vol. 17, Iss. 6, pp. 643-649
Closed Access | Times Cited: 1
Rodrigo M. Carrillo‐Larco, Wilmer Cristobal Guzman‐Vilca, Antonio Bernabé‐Ortiz
Primary care diabetes (2023) Vol. 17, Iss. 6, pp. 643-649
Closed Access | Times Cited: 1
Changes over time in the cardiovascular risk profile of type 2 diabetes from 2007 to 2020: A community‐based study
Brent A. Williams, Jonathan P. Brady, Stephen Voyce, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 7, pp. 1216-1223
Closed Access | Times Cited: 2
Brent A. Williams, Jonathan P. Brady, Stephen Voyce, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 7, pp. 1216-1223
Closed Access | Times Cited: 2
Cardiovascular Effects of Hypoglycemic Agents in Diabetes Mellitus
Anna Pietraszek
Current Drug Safety (2020) Vol. 16, Iss. 1, pp. 32-51
Closed Access | Times Cited: 2
Anna Pietraszek
Current Drug Safety (2020) Vol. 16, Iss. 1, pp. 32-51
Closed Access | Times Cited: 2
DPP4 inhibitors and respiratory infection, a systematic review and meta-analysis of the CardioVascular Outcomes Trials conducted before the pandemic and implications for the management of diabetes during COVID-19
G. Grenet, Samia Mekhaldi, Sabine Mainbourg, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
G. Grenet, Samia Mekhaldi, Sabine Mainbourg, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
L’aspirine a-t-elle une place dans la prévention cardiovasculaire primaire par la polypill ? Étude de simulation sur une population virtuelle réaliste
M. Fall, G. Grenet, Hai-Ha Le, et al.
Therapies (2023) Vol. 78, Iss. 6, pp. 667-678
Open Access
M. Fall, G. Grenet, Hai-Ha Le, et al.
Therapies (2023) Vol. 78, Iss. 6, pp. 667-678
Open Access
«Preanalytic validation» as a tool for working with a large number of assignments
V.P. Mudrov, D.V. Reshetnyak, O.N. Gudskov, et al.
Laboratory Service (2020) Vol. 9, Iss. 2, pp. 23-23
Closed Access
V.P. Mudrov, D.V. Reshetnyak, O.N. Gudskov, et al.
Laboratory Service (2020) Vol. 9, Iss. 2, pp. 23-23
Closed Access
